Cave A C, Horowitz G L, Apstein C S
Cardiac Muscle Research Laboratory, Whitaker Cardiovascular Institute, Boston University School of Medicine, MA 02118.
J Mol Cell Cardiol. 1994 Nov;26(11):1471-86. doi: 10.1006/jmcc.1994.1166.
Ischemic preconditioning in the rat significantly improves functional recovery following global ischemia by undefined mechanisms. It has been suggested that preconditioning protects by altering the tissue metabolic milieu during ischemia, either by increasing ischemic tissue accumulation of a beneficial substance (e.g. adenosine), or inhibiting tissue accumulation of a malefic component (e.g. protons). If this is the case, we hypothesized that no protection should be afforded by preconditioning against a prolonged period of hypoxia, since the continued coronary flow would prevent the accumulation of any metabolic products in the myocardium. To test this hypothesis, isolated buffer-perfused rat hearts were preconditioned by 5 min of ischemia + 5 min of reperfusion and then subjected to 30 min of ischemia, or 25 min of substrate-free hypoxia, or 60 or 90 min of hypoxia with substrate. Function was re-assessed after reperfusion/reoxygenation for a further 30 min and compared to non-preconditioned controls. Ischemic preconditioning improved functional recovery following 30 min of global ischemia (% recovery of developed pressure (LVDP) in control v preconditioned hearts was 31 +/- 4 v 66 +/- 6%; P < 0.05). Importantly, this protection was achieved almost entirely via a better preservation of diastolic function (end diastolic pressure = 78 +/- 3 mmHg in control and 40 +/- 5 mmHg in preconditioned hearts following 30 min of reperfusion; P < 0.05). However, no preconditioning-induced protection was observed following either substrate-free hypoxia or hypoxia with substrate (% recovery of LVDP in control v preconditioned hearts was 31 +/- 4 v 34 +/- 4% after 25 min of substrate-free hypoxia, 48 +/- 3 v 53 +/- 6% after 60 min of hypoxia + substrate and 25 +/- 5 v 30 +/- 6% after 90 min of hypoxia + substrate respectively). Furthermore, no protection by preconditioning against hypoxia-induced diastolic dysfunction was observed. We conclude that preconditioning protects against ischemic injury, but not hypoxic injury. Although hypoxia-induced injury may differ from that induced by ischemia, the results are consistent with the hypothesis that the continued presence of flow with hypoxia abolishes the protective effect of preconditioning. Furthermore, the results support the concept that preconditioning of the ischemic myocardium requires the accumulation of a factor in the ischemic myocardium, either to exert the preconditioning protective effect, or as a factor of injury against which preconditioning affords protection.
大鼠的缺血预处理可通过未知机制显著改善全脑缺血后的功能恢复。有人提出,预处理通过在缺血期间改变组织代谢环境来发挥保护作用,这要么是通过增加有益物质(如腺苷)在缺血组织中的积累,要么是抑制有害成分(如质子)在组织中的积累。如果是这样的话,我们推测预处理不应能对长时间缺氧提供保护,因为持续的冠脉血流会阻止心肌中任何代谢产物的积累。为了验证这一假设,将离体缓冲灌注的大鼠心脏进行5分钟缺血 + 5分钟再灌注预处理,然后分别进行30分钟缺血、25分钟无底物缺氧或60或90分钟有底物缺氧处理。再灌注/复氧30分钟后重新评估心脏功能,并与未预处理的对照组进行比较。缺血预处理改善了30分钟全脑缺血后的功能恢复(对照组与预处理组心脏的左室发展压(LVDP)恢复百分比分别为31±4%和66±6%;P<0.05)。重要的是,这种保护几乎完全是通过更好地保存舒张功能实现的(再灌注30分钟后,对照组舒张末期压力 = 78±3 mmHg,预处理组为40±5 mmHg;P<0.05)。然而,在无底物缺氧或有底物缺氧后均未观察到预处理诱导的保护作用(无底物缺氧25分钟后,对照组与预处理组心脏的LVDP恢复百分比分别为31±4%和34±4%;有底物缺氧60分钟后分别为48±3%和53±6%;有底物缺氧90分钟后分别为25±5%和30±6%)。此外,未观察到预处理对缺氧诱导的舒张功能障碍有保护作用。我们得出结论,预处理可预防缺血性损伤,但不能预防缺氧性损伤。尽管缺氧诱导的损伤可能与缺血诱导的损伤不同,但结果与以下假设一致:缺氧时血流的持续存在消除了预处理的保护作用。此外,结果支持这样的概念,即缺血心肌的预处理需要在缺血心肌中积累一种因子,要么以发挥预处理的保护作用,要么作为预处理提供保护所针对的损伤因子。